Loading...
XNAS
MMSI
Market cap4.95bUSD
Dec 05, Last price  
83.43USD
1D
-0.78%
1Q
-10.26%
Jan 2017
214.83%
Name

Merit Medical Systems Inc

Chart & Performance

D1W1MN
XNAS:MMSI chart
P/E
41.10
P/S
3.65
EPS
2.03
Div Yield, %
Shrs. gr., 5y
1.09%
Rev. gr., 5y
6.40%
Revenues
1.36b
+7.89%
166,585,000190,674,000207,768,000227,143,000257,462,000296,755,000359,449,000394,288,000449,049,000509,689,000542,149,000603,838,000727,852,000882,753,000994,852,000963,875,0001,074,751,0001,150,981,0001,257,366,0001,356,514,000
Net income
120m
+27.48%
15,778,00012,301,00015,588,00020,727,00022,530,00012,460,00023,044,00019,710,00016,570,00022,974,00023,802,00020,121,00027,523,00042,017,0005,451,000-9,843,00048,454,00074,516,00094,411,000120,357,000
CFO
221m
+52.12%
11,094,00019,106,00032,119,00027,967,00030,070,00034,760,00034,015,00046,938,00051,373,00053,325,00069,458,00053,599,00062,727,00086,533,00077,813,000165,270,000147,231,000114,291,000145,151,000220,799,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
IPO date
Sep 16, 1954
Employees
6,846
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT